ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,462,898, issued on Nov. 4, was assigned to Nykode Therapeutics ASA (Oslo, Norway).
"Method for selecting neoepitopes" was invented by Monika Sekelja (Oslo, Norway), Karoline Schjetne (Lommedalen, Norway) and Agnete Brunsvik Fredriksen (Raelingen, Norway).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for selecting neoepitopes for an individual, by selecting MHC I and/or MHC II binding neoepitopes and ranking them with respect the methods as described herein."
The patent was filed on Sept. 27, 2019, under Application No. 17/279,946.
*For further information, including images, charts and tables, please visit: http...